REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/20/2025
Back to search
Official data from USPTO
TRINTELLIX VORTIOXETINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
12/21/2025
Trademark type
Combined
Nice classes
5
Filing date
03/03/2016
Registration date
12/20/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/06/2024
Last transaction
12/21/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
99
Owner location
Valby, DK
Examiner
PEREZ,STEVEN M
Law office
L10
Current location
TMEG LAW OFFICE 101
Mark description
The mark consists of the wording "TRINTELLIX" in stylized blue-green font with the dot over the first letter "I" represented by concentric orange circles with the upper portion of each circle faded out. The wording "VORTIOXETINE" in stylized blue-green font is placed below the word "TRINTELLIX". The color white appearing in the drawing represents background or transparent regions and is not claimed as a feature of the mark.
Holders and representatives
Holders
H. Lundbeck A/S
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorderstrokedepressioncognitive disordersmood disorderspsychosisanxietyepilepsysclerosisporphyriaHuntington's disease and disorderinsomniaParkinson's disease and disorderschizophreniabipolar disorder and diseaseADHDcancerpainalcoholism and chemical dependency; diagnostic agentsreagentspreparations and substances for medical purposes; pharmaceuticals for treatment of cognitive disorders and diseases; all of the foregoing comprising or containing vortioxetine
Publications
History of USPTO decisions and trademark events.
46 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/06/2024
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/06/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/30/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/22/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
10/30/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/26/2023
ES8R
TEAS SECTION 8 RECEIVED
06/20/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/20/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/04/2016
PUBO
PUBLISHED FOR OPPOSITION
10/04/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/14/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/30/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/24/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2016
GNRT
NON-FINAL ACTION E-MAILED
08/21/2016
CNRT
NON-FINAL ACTION WRITTEN
08/21/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/27/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
07/19/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/28/2016
ALIE
ASSIGNED TO LIE
06/22/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/15/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/02/2016
GNSL
LETTER OF SUSPENSION E-MAILED
06/02/2016
CNSL
SUSPENSION LETTER WRITTEN
06/02/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/01/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/30/2016
GNRT
NON-FINAL ACTION E-MAILED
03/30/2016
CNRT
NON-FINAL ACTION WRITTEN
03/30/2016
DOCK
ASSIGNED TO EXAMINER
03/22/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/10/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2016
NWAP
NEW APPLICATION ENTERED
03/07/2016
Continuous trademark protection
Get notified about every new filing that threatens TRINTELLIX VORTIOXETINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.